Certified by Founder Lodge
HexemBio
United States - New York, NY
START UP
1 Disclosed Funding Rounds $10,400,000
0 Participating Investments
-
Founded date
2024
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
HexemBio is developing regenerative therapies based on the Synthetic Human Yolk Sac, a technology designed to rejuvenate aging blood stem cells by recreating the developmental environment whe
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 09 ,2026 | Seed | $10,400,000 |
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
Trent AI | $13,000,000 | (Apr 9, 2026)
E2 - Endovascular Engineering | $80,000,000 | (Apr 9, 2026)
GoSats - The simplest onramp to Digital Assets in India | $5,000,000 | (Apr 9, 2026)
Aria Networks, Inc. | $125,000,000 | (Apr 9, 2026)
